Chanaxin contains Tulathromycin, an antibiotic from the Macrolides class. It will come as a solution for injection and is intended for use in cattle, pigs and sheep. It is indicated for the following treatments:

  • Cattle

    • Metaphylaxis of Bovine Respiratory Disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis susceptible to tulathromycin.

    • Infectious Bovine Keratoconjunctivitis (IBK) associated with Moracella bovis susceptible to Tulathromycin

  • Pigs

    • Treatment and metaphylaxis of Swine Respiratory Disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Mycoplasma hyopneumoniae, Haemophilus parasuis and Bordetella bronchiseptica susceptible to tulathromycin. The presence of the disease in the group must be established before the product is used. The product should only be used if pigs are expected to develop the disease within 2-3 days.

  • Sheep

    • Treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent Dichelobacter nodosus requiring systemic treatment.

The product has only just received a positive opinion for initial marketing on the 16th February 2022 so it will be a while before it is released onto the veterinary market. We will provide more information on the product when it becomes available.

If you have any specific questions regarding Chanaxin please contact our customer services on [email protected].

Written by: Dr. Nick Garside BVetMed MRCVS